-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 AaJw8InRsGJWwZNOjA8azCChEX0M4uiry0ma4AnV5QRPP1l8tk/Q5mU7xTr8V0RD
 TrxSFzEDk8ONXrrIxnlJ6A==

<SEC-DOCUMENT>0001193125-09-200936.txt : 20090930
<SEC-HEADER>0001193125-09-200936.hdr.sgml : 20090930
<ACCEPTANCE-DATETIME>20090930132255
ACCESSION NUMBER:		0001193125-09-200936
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20090930
FILED AS OF DATE:		20090930
DATE AS OF CHANGE:		20090930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QIAGEN NV
		CENTRAL INDEX KEY:			0001015820
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28564
		FILM NUMBER:		091095011

	BUSINESS ADDRESS:	
		STREET 1:		SPOORSTRAAT 50
		CITY:			KJ VENLO
		STATE:			P7
		ZIP:			5911
		BUSINESS PHONE:		31-77-320-8400

	MAIL ADDRESS:	
		STREET 1:		SPOORSTRAAT 50
		CITY:			KJ VENLO
		STATE:			P7
		ZIP:			5911
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:4pt solid #000000">&nbsp;</P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 6-K </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>Report of Foreign Private Issuer </B></FONT></P> <P
STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>Pursuant to Rule 13a-16 or 15d-16 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="4"><B>under the Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the month of September, 2009
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Commission File Number 0-28564 </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="6"><B>QIAGEN N.V. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Translation of registrant&#146;s name into English) </B>
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Spoorstraat 50 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>5911 KJ Venlo </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Netherlands </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive office) </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Form 20-F&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman"
SIZE="2">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If &#147;Yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82-<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P
STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:4pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="toc"></A>QIAGEN N.V. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"
ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Form 6-K </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TABLE OF CONTENTS </B></FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:15pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Item</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Page</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx18976_1">Other Information</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx18976_2">Signatures</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx18976_3">Exhibit Index</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx18976_1"></A>OTHER INFORMATION </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On September&nbsp;29, 2009, QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) (&#147;QIAGEN&#148;) announced that the underwriters
for its offering of 27.5&nbsp;million newly issued common shares (the &#147;Offering&#148;) have exercised in full their over-allotment option to purchase 4,125,000 common shares (the &#147;Additional Shares&#148;), and QIAGEN will issue the
Additional Shares at the price for the Offering, as previously announced, of US$ 20.25&nbsp;per share (EUR 13.82). The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx18976_2"></A>SIGNATURES </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">QIAGEN N.V. </FONT></P> <P
STYLE="margin-top:18px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:&nbsp;&nbsp;<U>/s/&nbsp;&nbsp;&nbsp;&nbsp; Roland
Sackers&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U> </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roland Sackers </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer </FONT></P> <P
STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date:&nbsp;&nbsp;September&nbsp;30, 2009 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx18976_3"></A>EXHIBIT INDEX </B></FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:39pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:25pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release issued September 29, 2009</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:72px;margin-bottom:0px" ALIGN="right">

<IMG SRC="g18976g76a57.jpg" ALT="LOGO"> </P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:4pt solid #000000">&nbsp;</P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Contact: IR QIAGEN; email: <U>ir@qiagen.com</U>; phone: +49 2103 29 11710 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(Ad-hoc notification pursuant to Section&nbsp;15 of the German Securities Trading Act) </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>QIAGEN
Announces Exercise In Full of Over-Allotment Option by Underwriters in Offering of New Common Shares </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Venlo, the Netherlands &#150;
September&nbsp;29, 2009, </B>QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Stock Exchange, regulated market (Prime Standard): QIA) (the &#147;Company&#148;) announces that the underwriters for its offering of 27.5&nbsp;million newly issued common shares (the
&#147;Offering&#148;) have exercised in full their over-allotment option to purchase 4,125,000 common shares (the &#147;Additional Shares&#148; and, together with the 27.5&nbsp;million common shares, the &#147;Shares&#148;), and the Company will
issue the Additional Shares at the price for the Offering, as previously announced, of US$ 20.25&nbsp;per share (EUR 13.82). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The exercise of
the over-allotment option brings the total number of common shares to be sold by QIAGEN in the Offering to 31,625,000. Gross proceeds of the Offering (including the Additional Shares) are expected to be approximately US$ 640&nbsp;million (EUR 437
million). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company plans to use the net proceeds of the Offering to fund the acquisition of DxS Ltd. announced on September&nbsp;22, 2009
and potential future acquisitions, to strengthen its balance sheet and for general corporate purposes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deutsche Bank, Goldman Sachs
International and J.P. Morgan acted as Joint Global Coordinators and Joint Bookrunners of the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">QIAGEN N.V. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Spoorstraat 50 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">5911 KJ Venlo </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Netherlands </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">ISIN: NL 0000240000 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">German Securities Identification Number (WKN): 901626 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman"
SIZE="2">Common Code: 007994915 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>This ad-hoc notification does not constitute, or form part of, an offer or invitation to sell or issue, or any solicitation of an offer to purchase or
subscribe for, securities and any subscription for or purchase of, or application for, the Shares should only be made on the basis of information contained in the prospectuses (the &#147;Prospectuses&#148;) prepared by the Company in connection with
the Offering. In particular, any subscription for or purchase of, or application for, the Shares in the United States should only be made on the basis of information contained in the prospectus, including the prospectus supplement forming a part of
the automatically effective shelf registration statement in connection with the Offering. </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right">

<IMG SRC="g18976g76a57.jpg" ALT="LOGO"> </P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:4pt solid #000000">&nbsp;</P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The Company has filed a registration statement in the United States under the U.S.
Securities Act of 1933, as amended (the &#147;Securities Act&#148;), in connection with the offer and sale of the Shares. A written prospectus, including the prospectus supplement, satisfying the requirements of Section&nbsp;10 of the Securities Act
and containing the detailed terms of the Offering is available on the U.S. Securities and Exchange Commission&#146;s website at <U>www.sec.gov</U>. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>This ad-hoc notification does not constitute a recommendation. Prospective investors should consult a professional advisor as to the suitability of the Shares for the individual concerned. All
investments are subject to risk. The value of the Shares may fluctuate. An investment in the Company is speculative and involves a substantial degree of risk, including the risk of total loss of such investment. </I></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Prospective investors should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their
own assessments concerning these and other consequences of any investment, including the merits of investing and the risks. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any
investment decision. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>This ad-hoc notification does not constitute, and may not be used for the purposes of, an offer or an invitation
to subscribe for the Shares by any person in any jurisdiction in which (i)&nbsp;such offer or invitation is not authorised; or (ii)&nbsp;in which the person making such offer or invitation is not qualified to do so; or (iii)&nbsp;to any person to
whom it is unlawful to make such offer or invitation. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The distribution of this ad-hoc notification in certain jurisdictions may be
restricted by law, and therefore persons into whose possession this ad-hoc notification comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the
securities laws of such jurisdiction. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The content of this ad-hoc notification includes statements that are, or may be deemed to be,
&#147;forward-looking statements&#148; based on management&#146;s expectations, including, but not limited to, statements relating to the proposed Offering and the expected use of the proceeds from the Offering. By their nature, forward-looking
statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. The Company&#146;s actual results may differ materially from those predicted by the
forward-looking statements. The Company undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>This document is an advertisement for the purposes of applicable measures implementing Directive 2003/71/EC (such Directive, together with any applicable implementing measures in the relevant home
Member State under such Directive, the &#147;Prospectus Directive&#148;). A prospectus for the purpose of the listing of the Shares on the regulated market (Prime Standard segment) of the Frankfurt Stock Exchange was approved by the AFM and
published on September&nbsp;24, 2009 by being made available to the public, free of charge, in printed form at the registered office of QIAGEN N.V., Spoorstraat 50, 5911 KJ Venlo, the Netherlands, fax: (+31)-77-320-8409; email: ir@qiagen.com and
through the offices of the Joint Global Coordinators. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>In any EEA Member State that has implemented the Prospectus Directive, this
communication is only addressed to and directed at qualified investors in that Member State within the meaning of the Prospectus Directive. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman"
SIZE="2"><I>This communication is only being distributed to and is only directed at (i)&nbsp;persons who are outside the United Kingdom or (ii)&nbsp;investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005 (the &#147;Order&#148;) or (iii)&nbsp;high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d)&nbsp;of the Order (all such persons together being
referred to as &#147;relevant persons&#148;). The Shares are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such Shares will be engaged in only with, relevant persons. Any person who is not a
relevant person should not act or rely on this document or any of its contents. ### </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g18976g76a57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g18976g76a57.jpg
M_]C_X``02D9)1@`!`0$!,`$N``#_X0!.17AI9@``24DJ``@````$``$#!0`!
M````/@```!!1`0`!`````4?"`!%1!``!````S2X``!)1!``!````:2X`````
M``"@A@$`B+$``/_;`$,`!@0%!@4$!@8%!@<'!@@*$`H*"0D*%`X/#!`7%!@8
M%Q06%AH=)1\:&R,<%A8@+"`C)B<I*BD9'RTP+2@P)2@I*/_;`$,!!P<'"@@*
M$PH*$R@:%AHH*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*/_``!$(`((`H`,!(@`"$0$#$0'_Q``?```!!0$!`0$!
M`0```````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!````````
M`0(#!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1
M!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ
M0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25
MEI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3E
MYN?HZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/JFF331PINE8*O3FED<1QL[
M=%!)KFKN=KB0NY'08'I6M*ESOR$V;/\`:=OG'S_E5J&>.89C<-7+YY^Z`!4U
MM,T$J.HZ=OZ5O+#JV@KG35!<W<5OPY);^Z.33+JZ\NS\Y,$L!M_&N?F9GD+L
MV26R365*CSZL;9N+J=N6P=X]R.WK5U'5U#(P(/<5R>XD]?Q`JWI=PT-THY\M
M^#6D\.DKQ$F=%56:_MXFVEMS`XPO/-0ZO=-`@CC.'?J?05A<D^^?6II4.9<T
MAMG00ZG;2L`&*D]-PZU<5@P!4@@]Q7*+SC^>*U=$N/\`E@<<C<#FG5H**O$$
MS7)`!).`*I/J=NIP"S>X%5-7NB9#;@[5&,^YK)`(;UQUHIT$U>0FSI8+Z";A
M6VGT;BK-<@./I@\?TKHM)N/.M]K9W)QSW':IK4>170)EN618D+2,%4=S5-M3
M@4_QXYYQ67>W+W-P1DE%;"@?SJJQ'<YQFKAAU;W@N=/!<Q3_`.K8$CJ#UJ6N
M7B9E(=,AACZBNDMY!-"D@[BLJM+DU0T[B7:[K651DDJ<8KEFSAL\`X-==6+J
M&EN9&DM\,IYV=P?:KP]11T8-&6I'&1TZ<]*<"'X/;(IRVTY(_<2CGLAK2T_3
MG!5IAM4<[?7Z^U=,ZD8J]Q6)-0C*Z3&&ZH!D8]JPRW?.#D5UTB"2-D;E6&#6
M#<Z7-$Y,:^:A.1Z_C6-"HK68-&<I&0/7K5BT^:ZC3!()'%"6<[-@0R9SU*D8
MK7TNP-O^\GQYO0`=%K:I4C&(DB#7E(DB;.`1BLOD=,8R1_\`6KIKRW6Z@,;'
M'<'T-8%QI]Q$<>66&>"O(K.A4BX\K&T5Q[Y/XU>T1";Q6`)`4DFH(;*XD;Y8
MF`/<\"MS3[)+2/UD/WFIUJD5%KJ"1D:K&5O9223G!&:J$[5.3QGIFNAU*S^U
M(-K;77IGO6%)9W$9P\+]3RHR*=&HI12;$T1`[@?H1@5L:$I,4QQ@'`!_`_XU
M0M=.GF?#H47H2W&*Z&"%((A'&,**C$5%;E0TCF)!LF93@$,>E)QCUXK8U'33
M-(98<;CRRGC-9KVDX8[H9"1_LYK2%2,E>XK$>3VZ\=ZZ'3%*648;W/ZUF66E
MNT@>8;$QG'<UN*`J@*``.`!6&(J)KE0T@KF/%?B^TT%A`J?:;L\F-6QM'N?7
MVK=U:Z^PZ9=77!,4;.`3C)`X'YU\_7KR7-S+-,Y>1VRS,>6[\G^M;8#"QKMR
MGL@D[':_\+(U'S,_9K4K_="MS[]?\XKK_"_C&RUQUMV'D7A!(C)RK#_9->*-
M]T9RP)X[9_PJ:SN7M)HKB!RLT1WJP]0>&_\`K5Z-7`4IQM%69"DSZ,KA?$GQ
M!M["9[?3(1=2J<&1B0@/IZG]*M>,=:D3P1#=0L8I;U(QD'E0R[C^G'XUX\XZ
M8/L,&N+!8.,TYU/N*E+L=];_`!*OA*//M+5DW<A=RD^P))YKO/#OB"RUZ%FM
M&99$`WQN,$9_F.M>"``XP<^P/7V_^O6]X*U.33_$=G)&3LE80R#IN4G'/T.#
M75B<!3<&X*S1*DSW"YGBM;>2>X<1Q1J69CT`%>>:M\2=EPT>F6T9B4D>;,2<
MC^]M&,#K2_%S5)(ELM.C)"/^]E`[C.!_7BO,3@GWSN^GO_\`6K'!8*$X>TJ:
MW'*71'H^F_$F?SU&H6D30'&6AR&7\"<'VZ5Z%I6HVVJV275G)OB;@@\%3W!'
M8U\[1GG+'``[=O\`/Z5WWPGU22/5I;`N3!-&75>RN/\`ZV?TJL9@8*#G35F@
MC(])U?5+32+)KJ^E"1C@#J6/H!W->=WWQ(NVF/V&TA2$'`+DLQ_E6;\3=3DN
M_$4EMG,%J`BKG@L0"3['_"N15O;/<^_O3PF!AR*<U=L)2?0],T7XD))-Y>K6
MZQJ1Q)#DCZD'M_G%>A0RI-$DL3!XW4,K#H0>AKYP##`]2.#_`%_^M7K7PMU1
MKC1KFVG8G[(P*DG.$8'C\P?SK+'8.-./M*:",NC-SQ/XEL_#\*F?,MP_*0J<
M$CU)["N(D^)&H%\I:VR@'[ASGZ9SUKD=<OI=4U:YNY6R7<X!.=H[`>V*H,I+
M`<9Z<?R_^O730P%.,??5V)R=SV'PYXXL]2D2WO5%K<N0%.<HQ],]C[?K77U\
MXAB'!!.X8Q_G^M>\^%+Y]2\/65U*<R.F'/J5)4G\<5PX["1HVG#9E1E?1EG6
MK0WVDWEJN-TL3(N3QDCC]:^?[J-XY7CD7#J=K#'3'8^U?1E<EXK\%6NLS-=6
MSBWO".3CY7/O1@,5&BW&>S'*-SQSG<`<@=B>_P!?Z4L,,D\J1HI>20X4`<EB
M<#\:[0_#O6-X3S+7:#G?YAQ_+-=AX1\'6^A/]HGD%S>8PKXP(_7'O[UZ-7'4
MH1NG=D*+ZE3QKH\W_""VMO'\[V*QL^WN%4J2/SKR1N.?0\?_`%O:OI!U5T9'
M`96&"",@BO._$7PY6>=I]'F6(,<F&3H/]TUQX'&1BG"H[%2C?8\Q!R`P[9SS
MQC_"MGP=82ZCXAL8XPWRR"1R!T53DD_TK<M?ASJ\DNV>2W@CSRV_<?P`_P#K
M5Z)X7\.VGA^T*0?O+AQ^\F8<M[#T'M73B<=3C!J#NQ1B^IR'Q=TUG-GJ*+E5
M'DO[<EE_]FKS3JG\0[YQ_GFOHV^M(+ZTEMKN)98)1M9&[C_/>O-]7^&TXF9]
M*N8GB/\`!,2&'T(X)_*L<%C(1A[.;M8)1['G0W`!5!SUR!_+^M=W\*-.DEUF
M2]*XAMXMF<8!9NP]L9_2IM-^&MXTBG4+N&*/K^Y)9OPR`!^O2O2M-L+?3;*.
MULXQ'#&.`/YFGC,;!P<*;NV.,>YY!\2K![3Q//*^/+N@'0]<\8(/XBN3R>5Q
MNYZ_X_TKZ!\0:)::Y9?9[Q2"IW1R+]Y#[?X5YUJ/PWU))&-E<03QY^7<2K?B
M,8_6KPN-IN"C-V:%*+Z'!*X)W!F/&<]__P!=>M?"C3I(=(N[J8$)=,`@/<*#
MD_B2?RK.T+X;.LT<FL7$9B7&88B26^K<8_"O2HHTBC6.)52-`%55&``.@%8X
M[&0G'V=/4<8VU9\^ZUI\NEZG/:S`J\3D#`['N/8YS5%0#T/;TX__`%5[AXJ\
M*6>OA9'8P72C`E09SZ!AWKAC\-M6#$"XLV&.#O88/_?-=5''TIQ7,[,EQ=]#
MC$7<_)ST!_SZ5[OX2L7T[P[96TF?,";F!&""Q+8/TSC\*P_"O@>'2;A;J^E6
MYN%P44+A$;U]_;IBNSK@Q^*C5M"&R*C&VX5\Y?&3X\W&FZC<:+X*,7F0DI/J
M+`/\PZK&IXXZ;CG/.!QD^V?$/4)M*\!^(+ZT<I<P6,SQ..JOL.#^!P:_/61F
MW9;DUU9-@J==RJ5%=+H$WT.T/Q4\<?:Q<?\`"3ZH)`=VWS3L_P"^/N_ABO</
M@M\=YM:U*VT+QEY0NIV\NWOT`0.YZ+(HX!/0$8'08[U\KALC.:DB+(P=6(*D
M$$'%>[B,OH5H.+BEYHS3:/TCU"]MM.L;B]OID@M;=#)+(YP%4#))KY,^(W[0
M6NZK>2V_A1SI.G*2JR!0T\H[,2<[?H.GJ:[OXX^(KZX_9\\.W+.1-JXM%NCC
M[P,1D/YLH-?*+#:?YUY64Y?3:=2JKN]O+0N;.ZT[XM>.M-G$\7B34)6SDK</
MYRGVVOD5]-?!'XO0>/HWT[4X8[/7H4WE$/[NX0=63/0CNO/J.^/BMVZ`8QVK
MIOA?J4^D_$3P]=VKLLBWL2G!ZJS!6'X@D5Z&-R^C6I.T4I+9HF+LS[H\=>+-
M-\%^'9]7U=R(H_ECC7[\KGHB^_\`(`FOD7QE\=/&.NWLIL;\Z19$_NX+/Y6`
M]W^\3^('L*[+]L/5)W\0Z'I.XBVBM3<XSPS.[+^@3]37SH<[AZ5RY5@*2I*K
M-7;_``')ZV/3?#'QK\;Z'=J[:Q-J,(.7@OOWRL/3<?F'X$5];?"_Q]IOQ`\/
MC4-/!@N8R$N;5VRT+_7NI['O[$$5^?Z]<9X/ZU[-^REJD]G\3Q9QES!?VLL<
MB]@5&]6_\=(_X$:O-,!2E2=2"LUKH$7J?0_QB^)UC\/-*C_=K=ZQ<@_9K7=@
M`=W?T4?F3P.Y'RGKOQB\<ZO>/.^O7=JA/RQ6;>0JCT^7!/XY-6/VB-3GU/XK
MZV)V;;;.MM$I/"JJCI]3N/XUYO@[@!BM,NR^E3I1G)7D]=12;;/8O`GQ[\4Z
M%>1)K5PVLZ;G#QW&/-`[E9.N?][(^G6OKOPUKEAXDT.TU;29A-9W*;T;N/4$
M=B#D$>HK\X=OS<<&OJ3]D36)T\,>)[*7+VUC)'=1KW!=7W#_`,AC\S7)F^`I
MJG[:FK-?C<<'K8W?C?\`&Q?"%W)H?AR..XUA5_?SO\R6Q(X`'\3XY]!QUY`^
M>KSXJ^.+JZ,\GB;4U;.<12^6O_?*X'Z5R.L7]QJ6JWE]=.9+FYF:61V/)9CD
MG]:I*?[WX5Z.%R^C0II<J;ZMB;;/HWX5?M!7\>HQ:=XX=+FSE8(M^J!'A/3Y
MP,!E]\9')YKZA1E=59"&5AD$'((K\T\_GFON[X":A<:I\(O#EQ=OOE$+P[O]
MF.1XU_\`'5%>/G.!IT4JU-6N[-%0?0['7=-AUG1;_3+DL(+RWDMW*]0KJ5)'
MOS7Y]>,?#E_X5\17FD:K$T=S;L1D#Y77LRGN".17Z)US?C7P1H'C.S6#7[!)
MR@_=S*=LL?\`NL.<>W3VKDRW,/JDFI*\65*-S\]2*Z#P-X5U#QAXEL]'TN)F
MDF;,CX^6&,?>=O0`?GP!R17TZO[-7A,3;O[2UKR\YV>9'_/97J/@WP=H7@ZP
M-KX?L([97QYDGWI)2.[,>3].@[5ZV(SNDH/V6K)4.YS?Q4\!)X@^%I\/Z6@\
MZPBC:Q4GJT2[0OU*Y7ZFOAV[@FMKF6&ZC>*6-BCQR`JRL.""#T.:_2:N$\>?
M"KPMXUE:XU.S:"_(P;NU81R-_O<$-^()KSLMS/ZM>%75/4J4;GP4PPW`&/3O
M7K'[.7@>Z\3^.+34I(F&DZ5*MQ-*1A6D7E$'J<@$^P]QGVS3_P!F_P`'V]RL
MES=:K=Q@Y\IY453[':H/Y$5Z]HND:?H>FPZ?I%I#9V<0PD42X`]_<^YY-=F-
MSFG*FX4=WU["4.YXM^U7X)N=<T"T\0:;"TT^F!EN$1<L83SN^BG)/LQ/:OD9
ME/0^O2OTPKRKQ=\"/!OB*\>[2"XTNX<[G-BX1&/^X00/PQ6&6YK&A#V579;,
M)1OJ?$H4@8SBOIO]DSP3<0/=^+;Z)HXI(C;60=<%P2"\@]N-H/?YO2NW\-_L
M_>#-&O$N;E;S5&0Y6.\D4QY]U51GZ'(KUN*-(8DCB14C0!511@*!T`'85689
MM"K3=*CUW81C;5GR5^U7X(N=/\4?\)/:1,]AJ`43.HXBF4`8/^\`"/<-7@Q!
M!&>M?I3?V=MJ%G-:7T$5Q:S+MDBE4,K#T(->0ZY^SKX-U&[:>U?4=.#')B@E
M5D'T#*2/SJL#G$(4U3K=.H2C?4^-U5G8;!D]!CKFOM?]G3P1/X0\#M)JD)BU
M/4W$\T;KAHXP,(C>^"21VW$=JT/`WP;\)>$+N.\M;66]OXSNCN+UA(8SZJH`
M4'WQGWKT:N?,LT6(C[*EL.,;'P1\8/!-UX(\97=E)$WV"9FFLYL<21$\#/J.
MA'J/0BN("X`.:_1CQ/X<TCQ1IC6&O6,-Y:GD*XY4^JD<J?<5Y-<_LV>$9;DO
M%?ZS#$3GREEC('L"4S^==V%SNGR)5M&OQ)<.Q\IZ%I%[KNK6NF:7;/<7MPXC
MCC4=2>Y]`.I/8#-??O@/P[%X3\'Z5HD+!A9PA7<9P[DEG89]6+'\:I>!OA]X
M<\$PL-"L0EPZ[9+F4[YG'H6/0>PP/:NKKS,SS'ZVU&"M%%1C8*\S^+7Q+7PG
MC3=+$<NKR)N9FY6!3T)'=CU`_$^_I;$*I8]`,U\?V,4OCGXD0I>2/C4+W,AS
MRJ9R0/HHP*^>QE:5.*C#=GT7#^7TL34G6Q'P4U=K^O1FA9VWC?Q_,T\2ZC?1
MY/[QWV1#U`)(4?04R[B\<_#VY2XD>_LHPV`V_P`R%CZ'JI^AKZML;2WL+.&T
MLXDAMH4"1QH,!0.U,U73[75=.N+&_A6:UG0HZ-W!_D??M6?U!6OS/F[G8N)T
MY\CHQ]EVMK;\OP.#^$7Q&3QI:26M]&D&L6Z[G5/NRITWKZ<XR/<8]O&_B%XM
M\1V?CO6K6VUS4X(([IUCCCN7557<<`#.,5E^'VF\'_$^!8Y6)LK\VSGIO3>4
M;CW&:@^*#$_$37&88Q>2#]:XZN(G.C:3U3L>]@\JH4,=*4(IPG&Z3UMJC[%K
MYR^-GCO58_&4NGZ'J=U9V]D@B?[-,4#R=6)QZ9"_\!->]>)]7AT#P_?ZI<D>
M7:Q%\$XW-T5?Q)`_&OE?X=Z3+XS^(ENM\&GBDF:[NR1PR@[CGZG`_P"!5VXZ
MH_=I0W9\]PWAJ:]KC:ZO""Z]]_R_,[GX!^-]3O/%5QI.MZE<WBW<):`W$K2%
M73G`STRN[\A7N'B/6K/P]HUSJ>HN5MX%R0.2QZ!1[D\5\G:W!/X%^)5Q]E5E
M.G7HDB!;[T>=R`X]4(S]37H?[1/B$:EIGAVVLF8V=U%]O_WMP`3\0"WYUA1Q
M+I4IQEO$[LQR>&+QU&=)6IU%=V\E?\58Y+Q+\0O$WC+4S:V+W,4$C$165ENR
M1[[>6/Z>PJ&;X?>.K2T6_33;],C.8Y@91]5#;OTKUW]GKPU:Z=X0CUHQ*;_4
M"_[PCYDC5BH4>Q*DGUR/05Z3J.K:;IA0:EJ%I9E\E?M$RQ[L=<9(S54\)[6'
MM*TM63BL]6"K/"8&BN6.CTWMOM^;N?//PU^+.JZ+JJ:5XLFENK%G\HRS`F:W
M;..3U(]0>1VZ8/1_M!>(-7T?5-(72M4NK.&6!F86\Q3<=W4XKOS/X#_MM]9:
M\\/'4V`!N6N(BW'0C)X//4<XQZ5Y)^TA>VVIW^A2Z?=074!@D(DAD#J?GQP1
MQV-%52I4))SOV#!2H8S,Z<XT.2Z?-=:-VZ*W_#]C`TBX^)>LV*7FEW6OW-JQ
M(61+AL$C@X.:[KX;1>.K6;79O$\FKK;KIDIA:ZF9@LHVD$9/!P#S61\.?BQI
MOA7PE::1=Z?=S2P,Y,D97!W,6[GWKO/#_P`3+#QG;ZU96=C=6[06$LY:4J00
M!C''^]48?V3Y7SOF[&V9RQ:]I#ZM%4[_`!65[7WW/#]"^)GB;2=;MKJXU2]O
MH(W_`'EO/,S+(O<<]..A[5]7Z+JEKK6E6NHZ?();6X0.C#^1]"#P1ZBOC+0]
M"N_$-]+:Z8GFW"Q/,(QU8*,D#U)[#O7H'P,\=_\`".:F=$U60KI=W)\CN>()
M3QG/H>`?3@^M9X/$RIRM/X6=/$&3T\13]IADE."U2ZKT_+YEGXU^*M?TKX@7
MEKINKW]K;+'$1%%,5490$X`KWOPA-+<^$]%GN)&DFELH7=W.2S&,$DGUS7S7
M\?B3\2[T<\1P_P#HL5](^"B6\':$6SDV$!.?^N:UU8:3=>HKGC9S2A#+<+*,
M4FTK_<C9(!!!Z&OD:\AF^'WQ+#R1LPT^Z$BC/^LB)R/S4U]<UQGQ(\`V7C2R
M1F86VIP*1#<A<Y']QAW7^1Y'<';%T'5BG'=;'#D68T\'5E3K_P`.:L_\_P`6
M=%I.KVFN:2M]HMS#<1RIE&SP&QT8=0?4=:\=U#XN>(=`\6-I_B/2K-+:%RLR
M6X;>5[,C%L'L>G/M7'S^`O'7A:Y<Z9!>#).)M.E+!\=\*<_F!5-?`GCCQ'>/
M-=:;?23D?--?/Y9(^KG)KDJ8BO))*+4E]Q[N"RC+Z3G.K5A.FUI=V:^=ROX2
MMYO&7Q3MY?+Q]HO3>3`<A4#%V_P_&J?Q.CQ\0]<"=3>2'I_M5T7PCU74O!_C
M.YL[C1;BX\W%O=+'`S30<]1@=/4=^/:M3QI\,_%>K>+]5U"TT])+6>Y>2-C<
M1@E2>#@MD<5S>RE.CHFY7U/9>+A0Q]JLE&FH)1;:UU_K\SI?VDM=\G2K#0X9
M`)+A_M$P!_@7A0?8L2?J@KS#X;^,F\$W-[<P:=#>2W*+'N>0J44')`P.YQ^0
MKKOB%X#\;^*/%][J*Z6@MW?9#FZB&(UX7C=Z<GW)KV30?!6AZ7HUG92:787$
MD,2H\LENC-(P'+$D9Y.375[&K6KN?PVV/$6-P.7Y=##3M4YM9)/YZV^2\['R
M[\0/%;^+]<_M-[&*T?REC*HQ;=@GYB?7''T`IVJ2R:QX$TZ4*6DTB5K64\DB
M.0[XR?;<)!_WS7TCXX\":7K'A>_M=-TNPM[\IO@DB@1&WKR!D8P#C'XUYC\.
M?AYXETG79(==T='T2^A>VO%^T1M\IY5@`V<A@IR.1SBL:F$JJI9Z\V[.["YU
M@YX52A:#IO2+>K5NE]]&TO,Z/]GWQ=9W7AN+P_<2K%?V;-Y2N<><C,6X]P21
MCTQ[XZ'XH?#Y_&\FGO'J*V9M5=3NAW[MV/<8Z5Y/XN^#>N:->-<>'MVHV@;<
MA0A9H^>`1GD^Z_D*RGL_B9<1"R:'Q*T1^7:_FA?Q)XQ6JJSA#V-6#9QO`T:N
M)^OX#$QC>[UMHWOH_P`FCG?'.AVWAO7'TRVU.+4FC4>9)''M"OW7J<D<=^^.
MU;7Q#TN71O#'@R&Y3$[V4CLI&"NZ0N`?<!P*[SX:?!NY@U"/4_&`BQ$0\5DK
M!RS`]9".,#T&<]\8P=?XW>"M=\4:MILVC627$,$!1B943#;B?XB,]JR^JS]G
M*?+9O9?,[_[:H/%T</[5-1NY2=DF[->G4ROA7\,?#WB'P39:IJL5R]W<-)NV
M3%0`'*C`'L*[BT^'^@^%-,UJZT>&=)IK"6%C)*7&TKD@`^X%>06?PY^(MI;B
M&UCNK>(=$CU!%4?@'KLOASX4\::?-KG_``D*W#Q7&G2PP++>+*#*<;1C<<<9
MYK>AI:+I:]['EYCS2<ZBQJE%N_+S=+[;]#A/V>@#\1X2,\02\_A6Y\>/`"Z=
M=-XBTJ'%G._^E(H_U4A/WO8$_D3[BK_P>^'_`(E\.^-8[_5]-%O:+%(ID\^-
M^2..%8FO<]0LX-0L9[.\C$MO.ACD0]U(P:,/AN>@X35G<69YPL+FD<10DI1Y
M4G9W35WIZGP_JNI7>HW237LIFF5$C#MUVHH51^0%?9W@H;?!VA#TL(/_`$6M
M?.WB'X-^*+?6+F/1[$7E@KDPS&XC4LO;(9@<]CQUKZ1\-VTMGX=TNUN4V3PV
ML4<B9!VL$`(R.#R*,!2J0G+G0<48S#8BA16'FGY)K33MT-&BBBO4/BPHHHH`
I``"2``3UHHHH&PHHHH$%%%%`!1110`4444`%%%%`!1110`4444`?_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
